Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Diphenhydramine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001639 AN002682 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST002248 AN003674 Quantitative multi-Omics analysis of paclitaxel-loaded Poly(lactide-co-glycolide) nanoparticles for identification of potential biomarkers for head and neck cancer Cultured cells Human Cancer University of Sharjah AU
ST002447 AN003988 Bioactive molecule(s) of gut bacteria of Crocodile (Crocodylus palustris) as potential pharmaceuticals Pseudomonas aeruginosa Bacterial infection Sharjah Institute for Medical Research AU
ST002016 AN003284 Metabolomics of COVID patients Blood Human COVID-19 University of Virginia intensity
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001844 AN002987 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) Blood Human Fatty liver disease University of California, Davis normalized peak height
ST001844 AN002987 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part III) Liver Human Fatty liver disease University of California, Davis normalized peak height
ST002003 AN003266 A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 4) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome Columbia University normalized peak height
ST002498 AN004655 Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort Blood Human Cancer Weill Cornell Medicine peak area
ST000291 AN000464 LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice Urine Human University of Florida Peak area
ST000292 AN000466 LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice Blood Human University of Florida Peak area
ST000692 AN001070 Metabolites produced by strains associated with inflammation Bacterial cells Treponema Inflammation University of Michigan Peak area
ST000694 AN001074 Differences in bile acids composition between ASCL5 knockout and floxed mice. Intestine Mouse University of Michigan Peak area
ST000775 AN001223 Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study Blood Human Depression University of Michigan Peak area
ST002819 AN004591 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002820 AN004595 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002088 AN003407 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002089 AN003411 Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. Blood Human COPD National Jewish Health relativeMedian
ST000974 AN001595 GC6-74 matabolomic of TB (Part 1: Plasma) Blood Human Tuberculosis Max Planck Institute for Infection Biology scaled units
  logo